Evidence map›Paper›PMID 30674824›Full record

ArticleGels (Basel, Switzerland)2018

Ultrashort Self-Assembling Peptide Hydrogel for the Treatment of Fungal Infections.

Alyaa A Albadr, Sophie M Coulter, Simon L Porter, Raghu Raj Singh Thakur, Garry Laverty

Abstract read
In one paragraph

Article in Gels (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Alginate-Based Bio-Composites and Their Potential Applications.Journal of functional biomaterials · 2022
    Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Eukaryotic Cell Capture by Amplified MagneticFrontiers in microbiology · 2021
    Article
  11. Article
  12. Article
  13. Antifungal Peptides as Therapeutic Agents.Frontiers in cellular and infection microbiology · 2020
    Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Alyaa A AlbadrBiofunctional Nanomaterials Group, School of Pharmacy, Queen's University Belfast, Medical Biology Centre, 97 Lisburn Road, BT9 7BL Belfast, Northern Ireland. aalbadr01@qub.ac.uk.
Sophie M CoulterBiofunctional Nanomaterials Group, School of Pharmacy, Queen's University Belfast, Medical Biology Centre, 97 Lisburn Road, BT9 7BL Belfast, Northern Ireland. scoulter14@qub.ac.uk.
Simon L PorterBiofunctional Nanomaterials Group, School of Pharmacy, Queen's University Belfast, Medical Biology Centre, 97 Lisburn Road, BT9 7BL Belfast, Northern Ireland. sporter13@qub.ac.uk.
Raghu Raj Singh ThakurBiofunctional Nanomaterials Group, School of Pharmacy, Queen's University Belfast, Medical Biology Centre, 97 Lisburn Road, BT9 7BL Belfast, Northern Ireland. r.thakur@qub.ac.uk.
Garry LavertyBiofunctional Nanomaterials Group, School of Pharmacy, Queen's University Belfast, Medical Biology Centre, 97 Lisburn Road, BT9 7BL Belfast, Northern Ireland. garry.laverty@qub.ac.uk.ORCID 0000-0002-1435-2942

Funding

Iraqi Ministry of Higher Education and Scientific Research (MOHESR) S 1786Royal Society IE160988Royal Society RG150171Wellcome TrustWellcome Trust 207618/Z/17/Z
6 · The paper itself

Abstract

The threat of antimicrobial resistance to society is compounded by a relative lack of new clinically effective licensed therapies reaching patients over the past three decades. This has been particularly problematic within antifungal drug development, leading to a rise in fungal infection rates and associated mortality. This paper highlights the potential of an ultrashort peptide, (naphthalene-2-ly)-acetyl-diphenylalanine-dilysine-OH (NapFFKK-OH), encompassing hydrogel-forming and antifungal properties within a single peptide motif, thus overcoming formulation (e.g., solubility, drug loading) issues associated with many currently employed highly hydrophobic antifungals. A range of fungal susceptibility (colony counts) and cell cytotoxicity (MTS cell viability, LIVE/DEAD staining

Indexed as

aspergillosiscandidiasishydrogelnanomaterialpeptideself-assembly

Identifiers

PMID30674824
PMCPMC6209295

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.